Journal ArticleOPEN ACCESS

Evaluation of the novel HISCL chemiluminescence enzyme immunoassay for laboratory screening of hepatitis C virus

Clinical and Vaccine Immunology (2016) 23(7) 652-654
DOI: 10.1128/CVI.00078-16
3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The hepatitis C virus (HCV) antibody assay remains the first-line screening test to identify HCV infection. The newly arrived HISCL Anti-HCV assay had a satisfactory seroconversion sensitivity. Its sensitivity and specificity were 98.97 and 100% for clinical samples. In general, the HISCL Anti-HCV assay may be a novel choice for clinical HCV screening.

Cite

CITATION STYLE

APA

Feng, S., Wei, B., Liu, Q., Wang, T., Li, D., Rao, C., … Wang, L. (2016). Evaluation of the novel HISCL chemiluminescence enzyme immunoassay for laboratory screening of hepatitis C virus. Clinical and Vaccine Immunology, 23(7), 652–654. https://doi.org/10.1128/CVI.00078-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free